Ehealth, Inc. key statistics and ratios
In fiscal 2025, Ehealth, Inc. had return on equity of 6.8%, an operating margin of 12.0%, debt equal to 19.1% of equity and a current ratio of 3.37. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 96.6% | 96.6% | 94.5% | 96.9% | 97.0% | 97.5% | 97.8% | 99.6% | 99.7% | 99.5% | 99.5% | 99.3% | 99.6% | 99.6% | 35.2% | 39.2% | 43.5% | 44.3% |
| Operating margin | 19.2% | 20.3% | 8.7% | 8.6% | 2.1% | −3.8% | −3.0% | 1.5% | −5.0% | 1.0% | 16.1% | 9.1% | −23.3% | −25.3% | −6.4% | 4.4% | 12.0% | 10.8% |
| Net margin | 11.4% | 10.9% | 4.4% | 4.6% | 1.0% | −9.0% | −2.5% | 0.2% | 13.3% | 0.1% | 13.2% | 7.8% | −19.4% | −21.9% | −6.2% | 1.9% | 7.2% | 5.4% |
| Free-cash-flow margin | 21.2% | 10.9% | 13.3% | 13.5% | 7.6% | −1.0% | 6.2% | 1.1% | −9.1% | −3.1% | −15.4% | −19.8% | −30.9% | −6.7% | −1.9% | −3.8% | −5.0% | −6.3% |
| Return on equity | 10.1% | 11.1% | 4.2% | 4.3% | 1.1% | −15.7% | −3.1% | 0.1% | 9.4% | 0.1% | 16.1% | 6.7% | −13.2% | −12.7% | −4.5% | 1.7% | 6.8% | 4.8% |
| Return on assets | — | 9.4% | 3.7% | 3.8% | 0.9% | −11.9% | −4.3% | 0.3% | 10.9% | 0.1% | 11.3% | 5.1% | −9.5% | −7.8% | −2.5% | 0.9% | 3.3% | 2.2% |
| Asset turnover | — | 0.86 | 0.83 | 0.83 | 0.99 | 1.32 | 1.72 | 1.74 | 0.81 | 0.63 | 0.86 | 0.65 | 0.49 | 0.36 | 0.41 | 0.47 | 0.46 | 0.41 |
| Current ratio | — | 7.36 | 7.61 | 7.50 | 4.57 | 2.49 | 2.43 | 2.73 | 6.12 | 2.58 | 1.84 | 3.92 | 5.40 | 6.62 | 4.87 | 3.69 | 3.37 | 9.95 |
| Debt to equity | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.6% | 0.0% | 0.0% | 0.0% | 10.2% | 11.2% | 11.6% | 19.1% | 21.2% |
| Interest cover (operating income ÷ interest) | — | — | — | — | — | — | — | — | — | — | — | — | n/m | n/m | n/m | 2.1x | 6.2x | 3.9x |
| Effective tax rate | 42.7% | 46.3% | 49.0% | 47.4% | 52.7% | — | — | 92.3% | — | 92.7% | 19.9% | 15.8% | — | — | — | 47.9% | 31.8% | 35.7% |
| R&D as % of revenue | — | 4.0% | 4.8% | 5.4% | 5.6% | 6.7% | 5.6% | 4.6% | 4.0% | 2.7% | 1.6% | 1.6% | 1.9% | 3.0% | 3.0% | 2.3% | 2.5% | — |
| Capital spending as % of revenue | 1.1% | 1.8% | 1.6% | 2.5% | 4.1% | 2.0% | 1.0% | 1.0% | 1.0% | 1.8% | 1.3% | 1.3% | 0.7% | 0.1% | 0.5% | 0.4% | 0.4% | 0.2% |
| Free cash flow ÷ net income | 186.7% | 100.5% | 299.4% | 297.1% | 790.5% | — | — | 721.7% | −68.5% | <−999% | −116.8% | −254.4% | — | — | — | −203.4% | −68.9% | −115.7% |
| Dividends and buybacks ÷ free cash flow | 102.5% | 149.2% | 125.9% | 44.8% | 433.2% | — | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | −6.5% | 52.0% | 36.9% | 31.1% | −0.3% | 55.3% | 41.7% | 15.3% |
| Operating margin | −74.0% | 35.7% | 4.2% | −37.9% | −77.1% | 38.7% | −3.3% | −81.8% |
| Net margin | −72.7% | 30.9% | 1.7% | −28.6% | −58.8% | 26.7% | −5.4% | −70.3% |
| Free-cash-flow margin | −51.8% | −9.0% | 67.9% | −70.4% | −47.4% | −11.1% | 40.5% | −16.2% |
| Current ratio | 6.33 | 3.69 | 2.58 | 2.98 | 5.91 | 3.37 | 7.59 | 9.95 |
| Debt to equity | 13.8% | 11.6% | 11.8% | 12.4% | 13.5% | 19.1% | 19.8% | 21.2% |
Moat
Moderate moat
How hard Ehealth's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 20 / 20
Net income has been a median 1.6% of total assets over 10 years.
- Durability 10 / 20
Operating margin has been a median -2.0%; its worst year was -39.9%.
- Discipline 8 / 20
The diluted share count rose 14.4% over five years; stock-based pay has been a median 5.0% of revenue.
AI disruption exposure: High. In this industry, the core product is information work that AI systems increasingly perform. The score above includes a 15-point deduction for that exposure (64 before it).
Compare with peers
- Goosehead Insurance, Inc. statistics
- Huize Holding Ltd statistics
- Crawford & Co statistics
- Hagerty, Inc. statistics
- Selectquote, Inc. statistics
Head to head: EHTH vs GSHDEHTH vs HUIZCRD.A vs EHTH
More: Insurance Brokers stocks compared, Financials sector, rankings of US companies